Lise El Omari: Join Us for a Free Gynea Webinar to Take Stock of Ovarian Masses on Ultrasound
Lise El Omari, Medical Director at Gynea, President of URPS Midwives Ile-de-France, shared a post by Gynea on LinkedIn:
“Free Gynea Webinar – 1 hour to take stock of ovarian masses on ultrasound!
I will be alongside Jean-Marc Levaillant , expert, co-president of the GREEG Research and Teaching Group in Gynecological Ultrasound and head of the DU ‘Ultrasound Exploration of Fertility’ at the University of Paris-Est Créteil to lead this one-hour webinar dedicated to the ultrasound classification of ovarian masses.
Whether you perform dating ultrasound in the context of abortion, obstetric or pelvic ultrasound, you have certainly already been confronted with an ovarian mass.
Functional cyst, corpus luteum, endometrioma, dermoid cyst, malignant tumor… This will be an opportunity to take stock of the precise tools for description and diagnosis assistance, based on concrete cases.
Meet us at lunchtime: come share your snack with us and chat with other practitioners!
A friendly and enriching moment, for both young practitioners and experienced sonographers.
Free registration here.”
Quoting Gynea’s post:
“The evaluation of ovarian masses remains a daily challenge in gynaecological imaging, between the need not to ignore a malignant pathology and the risk of over-treating benign lesions.
We are pleased to organize a webinar in collaboration with Jean-Marc Levaillant, obstetrician-gynecologist and head of the University Diploma ‘Ultrasound Exploration of Fertility’ in Créteil, to help sonographers better qualify these ovarian masses.
On the program:
- Know how to recognize the main benign ovarian masses
- Use simple criteria in a relevant way
- Define a course of action to be taken in the face of an unclassifiable mass
- Discover diagnostic tools
The webinar will be hosted by Lise El Omari Medical Director at Gynea. To register, go to the link in the comments.
Fellow sonographers, save the date!”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Nov 6, 2025, 12:13Marco Zaccaria: Next LejEndo Dives Into ICG Innovation in Surgery
-
Nov 6, 2025, 12:04Silvia Alvarez: Do Endometriosis or Adenomyosis Affect Oocyte Quality and Pregnancy Rates?
-
Nov 6, 2025, 11:59Mary Mulcahey: Culture Eats Strategy and Grit Fuels Growth
-
Nov 6, 2025, 11:46Connection Between Infertility Treatments and Stroke Risk – Reproduction and Fertility
-
Nov 6, 2025, 00:03Fertility and Sterility: Special Issue Explores Human Embryo Testing and Phased Validation
-
Nov 5, 2025, 23:51William Wallace: How Your Gut Microbes Help Set Your Body’s Internal Clock
-
Nov 5, 2025, 13:34Nibhash Kumar: When Embryos Stop Growing and the Hidden Reasons Behind Early Developmental Arrest
-
Nov 5, 2025, 13:29Ahsan Saeed: DNA From Three Parents Just Stopped a Life-Threatening Disorder Before Birth!
-
Nov 5, 2025, 13:24New Weighted Classification Criteria Refine Antiphospholipid Syndrome Research – Hæmatologi DK